Recalls from Breckenridge Pharmaceutical, Inc.
Breckenridge Duloxetine Delayed-Release Capsules
(opens in a new tab)
Moderate risk
,
FDA
,
Jun 8, 2026
,
Drug impurity
Breckenridge Pharmaceutical Duloxetine Delayed-Release Capsules
(opens in a new tab)
Moderate risk
,
FDA
,
May 6, 2026
,
Drug impurity
Data: Recall Canary
(opens in a new tab)